全文获取类型
收费全文 | 8306篇 |
免费 | 166篇 |
国内免费 | 49篇 |
专业分类
8521篇 |
出版年
2018年 | 16篇 |
2014年 | 14篇 |
2012年 | 871篇 |
2011年 | 961篇 |
2010年 | 246篇 |
2009年 | 118篇 |
2008年 | 718篇 |
2007年 | 727篇 |
2006年 | 678篇 |
2005年 | 530篇 |
2004年 | 476篇 |
2003年 | 517篇 |
2002年 | 415篇 |
2001年 | 280篇 |
2000年 | 324篇 |
1999年 | 155篇 |
1998年 | 39篇 |
1997年 | 27篇 |
1996年 | 26篇 |
1995年 | 30篇 |
1994年 | 40篇 |
1993年 | 35篇 |
1992年 | 36篇 |
1991年 | 36篇 |
1990年 | 39篇 |
1989年 | 43篇 |
1988年 | 54篇 |
1987年 | 36篇 |
1986年 | 38篇 |
1985年 | 48篇 |
1984年 | 28篇 |
1983年 | 31篇 |
1982年 | 35篇 |
1981年 | 39篇 |
1979年 | 19篇 |
1978年 | 25篇 |
1965年 | 21篇 |
1963年 | 13篇 |
1959年 | 17篇 |
1958年 | 67篇 |
1957年 | 68篇 |
1956年 | 77篇 |
1955年 | 49篇 |
1954年 | 54篇 |
1953年 | 55篇 |
1952年 | 50篇 |
1951年 | 42篇 |
1950年 | 26篇 |
1949年 | 29篇 |
1948年 | 17篇 |
排序方式: 共有8521条查询结果,搜索用时 0 毫秒
161.
Differential functioning of the Beck depression inventory in late-life patients: use of item response theory 总被引:1,自引:0,他引:1
The present analyses examined age-related measurement bias in responses to items on the revised Beck Depression Inventory (BDI) in depressed late-life patients versus midlife patients. Item response theory (IRT) models were used to equate the scale and to differentiate true-group differences from bias in measurement in the 2 samples. Baseline BDI data (218 late life and 613 midlife) were used for the present analysis. IRT results indicated that late-life patients tended to report fewer cognitive symptoms, especially at low to average levels of depression. Conversely, they tended to report more somatic symptoms, especially at higher levels of depression. Adjusted cutoff scores in the late-life group are provided, and possible reasons for age-related differences in the performance of the BDI are discussed. 相似文献
162.
Accumulated evidence from electrophysiology and neuroimaging suggests that face perception involves extrastriate visual mechanisms specialized in processing physiognomic features and building a perceptual representation that is categorically distinct and can be identified by face-recognition units. In the present experiment, we recorded event-related brain potentials in order to explore possible contextual influences on the activity of this perceptual mechanism. Subjects were first exposed to pairs of small shapes, which did not elicit any face-specific brain activity. The same stimuli, however, elicited face-specific brain activity after subjects saw them embedded in schematic faces, which probably primed the subjects to interpret the shapes as schematic eyes. No face-specific activity was observed when objects rather than faces were used to form the context. We conclude that the activity of face-specific extrastriate perceptual mechanisms can be modulated by contextual constraints that determine the significance of the visual input. 相似文献
163.
Many researchers have hypothesized relationships between personality disorders and gender role (i.e., masculinity and femininity). However, research has not addressed if people who are masculine or feminine more often meet the criteria for personality disorders. The present study examined whether college students (N = 665, 60% women) higher in masculinity or femininity more often exhibited features of the 10 DSM-IV personality disorders. Feminine men exhibited more features of all the personality disorders except antisocial. Dependent traits were associated with higher femininity and lower masculinity. Antisocial traits were associated with masculinity. Both men and women who typically behaved consistent with their gender had more narcissistic and histrionic features, whereas participants who typically behaved unlike their gender had more features of the Cluster A personality disorders. 相似文献
164.
165.
166.
Buchanan A Califano A Kahn J McPherson E Robertson J Brody B 《Kennedy Institute of Ethics journal》2002,12(1):1-15
Pharmacogenetics offers the prospect of an era of safer and more effective drugs, as well as more individualized use of drug therapies. Before the benefits of pharmacogenetics can be realized, the ethical issues that arise in research and clinical application of pharmacogenetic technologies must be addressed. The ethical issues raised by pharmacogenetics can be addressed under six headings: (1) regulatory oversight, (2) confidentiality and privacy, (3) informed consent, (4) availability of drugs, (5) access, and (6) clinicians' changing responsibilities in the era of pharmacogenetic medicine. We analyze each of these categories of ethical issues and provide policy approaches for addressing them. 相似文献
167.
This study investigated the relationship between dream emotion and dream character identification. Thirty-five subjects provided 320 dream reports and answers to questions on characters that appeared in their dreams. We found that emotions are almost always evoked by our dream characters and that they are often used as a basis for identifying them. We found that affection and joy were commonly associated with known characters and were used to identify them even when these emotional attributes were inconsistent with those of the waking state. These findings are consistent with the finding that the dorsolateral prefrontal cortex, associated with short-term memory, is less active in the dreaming compared to the wake brain, while the paleocortical and subcortical limbic areas are more active. The findings are also consistent with the suggestion that these limbic areas have minimal input from the dorsolateral prefrontal cortex in the dreaming brain. 相似文献
168.
Chapman E 《Journal of genetic counseling》2002,11(5):351-367
This paper examines some of the ethical dilemmas that arise when testing for the late onset, untreatable condition of Huntington disease (HD) specifically now that technology allows us to test younger generations of the family for the mutant gene. Drawing on interview data from families with Huntington disease, the reactions to testing and perceived impact on other family members are considered. These are discussed in the light of the possible lowering of the age of test applicants. This potentially raises problems for a younger generation as they are confronted with reproductive decisions that the older generation did not have to face. It also means that individuals have the prospect of living with knowledge of a future illness for much longer. 相似文献
169.
Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors 总被引:3,自引:0,他引:3
Bennett RL Hart KA O'Rourke E Barranger JA Johnson J MacDermot KD Pastores GM Steiner RD Thadhani R 《Journal of genetic counseling》2002,11(2):121-146
The objective of this document is to provide health care professionals with recommendations for genetic counseling and testing of individuals with a suspected or confirmed diagnosis of Fabry disease, with a family history of Fabry disease, and those identified as female carriers of Fabry disease. These recommendations are the opinions of a multicenter working group of genetic counselors, medical geneticists, and other health professionals with expertise in Fabry disease counseling, as well as an individual with Fabry disease who is a founder of a Fabry disease patient advocacy group in the United States. The recommendations are U.S. Preventive Task Force Class III, and they are based on clinical experience, a review of pertinent English-language articles, and reports of expert committees. This document reviews the genetics of Fabry disease, the indications for genetic testing and interpretation of results, psychosocial considerations, and references for professional and patient resources. These recommendations should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular outcome. The professional judgment of a healthcare provider, familiar with the facts and circumstances of a specific case, will always supersede these recommendations. 相似文献
170.